Skip to main content
. Author manuscript; available in PMC: 2022 Oct 1.
Published in final edited form as: Liver Int. 2022 Feb 15;42(4):829–841. doi: 10.1111/liv.15182

Fig. 4. Anti-CD47 antibody treatment attenuated AMLN-diet induced liver fibrosis.

Fig. 4.

Fig. 4.

Fig. 4.

Fig. 4.

(A) Representative image of Trichrome staining (top panel) and Sirius red staining (bottom panel) and quantification of liver sections from 3 groups of mice (Scale bar=100 μm); (B) Hepatic fibrosis related gene expression in liver by qPCR; (C) Representative liver immunohistochemical staining images for Collagen I (positive staining shown as brown color; Scale bar=100 μm) and the quantification data; and (D) Western blotting and quantification of liver α-SMA levels from 3 groups. Data are represented as mean ± SEM (n=8 mice/group). *P<0.05, ** P<0.01, and *** P<0.001 compared to LF; #P<0.05, ##P<0.01 compared to NASH-IgG